Dogwood Therapeutics, Inc. — Form SCHEDULE 13D/A
Filed October 27, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Sealbond Ltd filed an amended Schedule 13D/A on October 27, 2026, regarding beneficial ownership in Dogwood Therapeutics, Inc. (market cap ~$8.1M). The filing text provided contains no specific details on share counts, percentages, dollar amounts, or what changed from the original filing. The amendment details are not disclosed in this document.
Why this rating
Routine amendment filing; lacks concrete specifics on ownership changes. Cannot assess materiality without amendment details.
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.